Professional Documents
Culture Documents
Drug Study
Drug Study
DRUG STUDY
Name of Patient: ___________________________________________________ Age: __35____ Sex: ___F__ Room: ________ Date:
___________________________
Admitting Diagnosis: _______________________________________________ Attending Physician: __________________________ Diet: __________________
Generic Name: Pharmacologic HIV-infection, .A thymidine Contraindicated in CNS: asthma, CNS: anxiety, Monitor patient for
STAVUDINE class: nucleoside with other nucleoside patients hypersensitive fever, dizziness, depression, sign and symptoms of
(d4T) reverse transcriptase antiretrovirals analogue that to drug. headache, malaise, pancreatitis, especially
inhibitor prevents replication insomnia, nervousness, if he takes stavudine
of retroviruses, nervousness, peripheral with didanosine or
Brand Name: Pregnancy risk including HIV, by . neuropathy hydroxyurea. If patient
ZERIT category C inhibiting the CV: chest pain. has pancretitis,
enzyme reverse EENT: reinstate drug
transcriptase and GI:, diarrhea, conjunctivitis cautiously.
causing termination nausea, vomiting,
of DNA chain GI: abdominal Monitor liver function
growth. pain, anorexia, test result
pancreatitis,
constipation, Motor weakness,
dyspnea mimicking the clinical
Presentation of
Guillain-Barre
syndrome (including
respiratory failure)
Bibliography: _________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________________
DRUG STUDY
Name of Patient: ___________________________________________________ Age: ______ Sex: _____ Room: ________ Date: ___________________________
Admitting Diagnosis: _______________________________________________ Attending Physician: __________________________ Diet: __________________
Bibliography: _________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________________
DRUG STUDY
Name of Patient: ___________________________________________________ Age: ______ Sex: _____ Room: ________ Date: ___________________________
Admitting Diagnosis: _______________________________________________ Attending Physician: __________________________ Diet: __________________
MUSCULOSKELETAL Peripheral
: arthralgia, back pain, neuropathy appears to
myalgia be the major dose-
limiting adverse effect;
RESPIRATORY: it may or may not
dyspnea resolve after drug is
stopped.
SKIN: diaphoresis,
pruritus, rash, Monitor CBC results
maculopapular rash and creatinine.
Bibliography: _________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________________
DRUG STUDY
Name of Patient: ___________________________________________________ Age: ______ Sex: _____ Room: ________ Date: ___________________________
Admitting Diagnosis: _______________________________________________ Attending Physician: __________________________ Diet: __________________
DRUG STUDY
Name of Patient: ___________________________________________________ Age: ______ Sex: _____ Room: ________ Date: ___________________________
Admitting Diagnosis: _______________________________________________ Attending Physician: __________________________ Diet: __________________
. . Peripheral neuropathy
(pain, burning, aching,
weakness, or pins and
needles I the limbs)
and tell him to report
these immediately.
DRUG STUDY
Name of Patient: ___________________________________________________ Age: ______ Sex: _____ Room: ________ Date: ___________________________
Admitting Diagnosis: _______________________________________________ Attending Physician: __________________________ Diet: __________________
. . Tell patient to
monitor weight
patterns and report
weight loss or gain.
Explain to patient
who has difficulty
swallowing that
extended-release
capsules can be
opened and contents
mixed with 2
tablespoons of yogurt
or applesauce.
Caution patient not to
chew or crush the
beads while
swallowing.
Bibliography: _________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________________
DRUG STUDY
Name of Patient: ___________________________________________________ Age: ______ Sex: _____ Room: ________ Date: ___________________________
Admitting Diagnosis: _______________________________________________ Attending Physician: __________________________ Diet: __________________
DRUG STUDY
Name of Patient: ___________________________________________________ Age: ______ Sex: _____ Room: ________ Date: ___________________________
Admitting Diagnosis: _______________________________________________ Attending Physician: __________________________ Diet: __________________
Monitor CBC.
Report evidence of
bone marrow
depression.
stavudine 1169
Reactions in bold are
life-threatening.
Bibliography: _________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________________
DRUG STUDY
Name of Patient: ___________________________________________________ Age: ______ Sex: _____ Room: ________ Date: ___________________________
Admitting Diagnosis: _______________________________________________ Attending Physician: __________________________ Diet: __________________
. . Monitor liver
function tests and
blood chemistry
results.
Caution female
patient not to
breastfeed, because
she may transmit drug
effects and HIV to
infant.
As appropriate,
review all other
significant and life-
threatening adverse
reactions and
interactions, especially
those related to the
drugs and tests
mentioned above
Bibliography: _________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________________
DRUG STUDY
Name of Patient: ___________________________________________________ Age: ______ Sex: _____ Room: ________ Date: ___________________________
Admitting Diagnosis: _______________________________________________ Attending Physician: __________________________ Diet: __________________
DRUG STUDY
Name of Patient: ___________________________________________________ Age: ______ Sex: _____ Room: ________ Date: ___________________________
Admitting Diagnosis: _______________________________________________ Attending Physician: __________________________ Diet: __________________